These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29758184)

  • 1. Therapeutic Penetrating Keratoplasty Button Cultures in The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole Versus Placebo.
    Cho J; Prajna NV; Lalitha P; Rajaraman R; Krishnan T; Lin YB; Ray KJ; Lietman TM; Rose-Nussbaumer J;
    Am J Ophthalmol; 2018 Aug; 192():142-145. PubMed ID: 29758184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial.
    Prajna NV; Krishnan T; Rajaraman R; Patel S; Srinivasan M; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Porco TC; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2016 Dec; 134(12):1365-1372. PubMed ID: 27787540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: A Secondary Analysis of the Mycotic Ulcer Treatment Trial II.
    Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Das M; Ray KJ; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2017 Sep; 135(9):987-991. PubMed ID: 28817744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Value of Persistent Culture Positivity in Fungal Keratitis in the Mycotic Antimicrobial Localized Injection Trial.
    Pickel J; Narayana S; Krishnan T; Ramakrishnan S; Samantaray PP; Porco TC; Redd T; Lietman TM; Rose-Nussbaumer J
    Am J Ophthalmol; 2020 Jul; 215():1-7. PubMed ID: 32171765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
    Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Devi L; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2017 Jun; 135(6):520-525. PubMed ID: 28426856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Significance of Repeat Cultures in the Treatment of Severe Fungal Keratitis.
    Ray KJ; Prajna NV; Lalitha P; Rajaraman R; Krishnan T; Patel S; Das M; Shah R; Dhakhwa K; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    Am J Ophthalmol; 2018 May; 189():41-46. PubMed ID: 29438654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycotic Antimicrobial Localized Injection: A Randomized Clinical Trial Evaluating Intrastromal Injection of Voriconazole.
    Narayana S; Krishnan T; Ramakrishnan S; Samantaray PP; Austin A; Pickel J; Porco T; Lietman T; Rose-Nussbaumer J
    Ophthalmology; 2019 Aug; 126(8):1084-1089. PubMed ID: 30904540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
    Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Prajna L; Srinivasan M; Raghavan A; Oldenburg CE; Ray KJ; Zegans ME; McLeod SD; Porco TC; Acharya NR; Lietman TM;
    JAMA Ophthalmol; 2013 Apr; 131(4):422-9. PubMed ID: 23710492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
    Sun CQ; Lalitha P; Prajna NV; Karpagam R; Geetha M; O'Brien KS; Oldenburg CE; Ray KJ; McLeod SD; Acharya NR; Lietman TM;
    Ophthalmology; 2014 Aug; 121(8):1495-500.e1. PubMed ID: 24746358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.
    Rose-Nussbaumer J; Prajna NV; Krishnan KT; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; Oldenburg CE; O'Brien KS; Ray KJ; McLeod SD; Porco TC; Lietman TM; Acharya NR; Keenan JD;
    JAMA Ophthalmol; 2015 Jun; 133(6):642-6. PubMed ID: 25764482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Utility of Repeat Culture in Fungal Corneal Ulcer Management: A Secondary Analysis of the MUTT-I Randomized Clinical Trial.
    Ray KJ; Lalitha P; Prajna NV; Rajaraman R; Krishnan T; Srinivasan M; Ryg P; McLeod S; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    Am J Ophthalmol; 2017 Jun; 178():157-162. PubMed ID: 28385473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression Discontinuity and Randomized Controlled Trial Estimates: An Application to The Mycotic Ulcer Treatment Trials.
    Oldenburg CE; Venkatesh Prajna N; Krishnan T; Rajaraman R; Srinivasan M; Ray KJ; O'Brien KS; Glymour MM; Porco TC; Acharya NR; Rose-Nussbaumer J; Lietman TM
    Ophthalmic Epidemiol; 2018 Aug; 25(4):315-322. PubMed ID: 29718751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole.
    Rose-Nussbaumer J; Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; Oldenburg CE; O'Brien KS; Ray KJ; Porco TC; McLeod SD; Acharya NR; Keenan JD; Lietman TM;
    Br J Ophthalmol; 2016 Jul; 100(7):929-932. PubMed ID: 26531051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials.
    Prajna NV; Lalitha P; Krishnan T; Rajaraman R; Radnakrishnan N; Srinivasan M; Devi L; Das M; Liu Z; Zegans ME; Acharya NR; Porco TC; Lietman TM; Rose-Nussbaumer J
    JAMA Ophthalmol; 2022 Feb; 140(2):179-184. PubMed ID: 35024776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
    Prajna NV; Mascarenhas J; Krishnan T; Reddy PR; Prajna L; Srinivasan M; Vaitilingam CM; Hong KC; Lee SM; McLeod SD; Zegans ME; Porco TC; Lietman TM; Acharya NR
    Arch Ophthalmol; 2010 Jun; 128(6):672-8. PubMed ID: 20547942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing Azole Resistance: A Secondary Analysis of the MUTT I Randomized Clinical Trial.
    Prajna NV; Lalitha P; Rajaraman R; Krishnan T; Raghavan A; Srinivasan M; O'Brien KS; Zegans M; McLeod SD; Acharya NR; Keenan JD; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2016 Jun; 134(6):693-6. PubMed ID: 27054515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.
    Hoffman JJ; Yadav R; Sanyam SD; Chaudhary P; Roshan A; Singh SK; Singh SK; Mishra SK; Arunga S; Hu VH; Macleod D; Leck A; Burton MJ
    Ophthalmology; 2022 May; 129(5):530-541. PubMed ID: 34896126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amniotic membrane transplantation for persistent corneal ulcers and perforations in acute fungal keratitis.
    Chen HC; Tan HY; Hsiao CH; Huang SC; Lin KK; Ma DH
    Cornea; 2006 Jun; 25(5):564-72. PubMed ID: 16783145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal trephination penetrating keratoplasty for severe fungal keratitis complicated with hypopyon.
    Liu Y; Jia H; Shi X; Wang J; Ning Y; He B; Wang C; Zheng X
    Can J Ophthalmol; 2013 Dec; 48(6):529-34. PubMed ID: 24314417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pretreatment with antifungal agents on clinical outcomes in fungal keratitis.
    Sun CQ; Prajna NV; Krishnan T; Rajaraman R; Srinivasan M; Raghavan A; O'Brien KS; McLeod SD; Acharya NR; Rose-Nussbaumer J;
    Clin Exp Ophthalmol; 2016 Dec; 44(9):763-767. PubMed ID: 27329780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.